Short Therapy for Febrile UTI in Childhood

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Urinary Tract Infections
Interventions
DRUG

Amoxicillin and Clavulanic Acid in Oral Dose Form

50 mg/kg three times daily administered orally

Trial Locations (13)

20122

Fondazione IRCSS Ca Granda, Policlinico di Milano, Milan

31100

UOC Pediatria Ospedale Ca' Foncello, Treviso

32100

San Martino Hospital, Belluno

33100

ASUIUD Azienda sanitaria universitaria integrata di Udine, Udine

33170

Pediatric Department, Santa Maria degli Angeli Hospital, Pordenone

34074

Ospedale San Polo, Monfalcone

34137

Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste

35128

Department of Woman and Child Health, University of Padua City, Padua

40138

Policlinico S.Orsola-Malpighi, Bologna

48121

Santa Maria delle Croci Hospital, Ravenna

60123

Ospedali Riuniti di Ancona - Ospedale Salesi, Ancona

98124

A.O.U.G. Martino, Messina

00168

Fondazione Policlinico Agostino Gemelli - IRCCS City Rome, Rome

All Listed Sponsors
lead

IRCCS Burlo Garofolo

OTHER

NCT04400110 - Short Therapy for Febrile UTI in Childhood | Biotech Hunter | Biotech Hunter